| Analysis | Metabolite Name | Measured Value | Units | Protocole |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.22765 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.238067 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.268665 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.300237 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.308513 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 0.680723 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 1.27351 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 1.70458 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | 2.40244 | SI | P3 |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | SI | P1 | |
| Reversed phase POSITIVE ION MODE | Pyridoxamine | SI | P4 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|